Impact BioMedical receives patent for plant-based insect repellent technology.

Impact BioMedical Inc. (IBO) announced the issuance of U.S. Patent No. 11,985,973 for "Insect Repelling Composition," enhancing its 3F technology platform. This patent, along with an earlier one, covers plant-based formulations aimed at natural insect repellents, potentially reducing insect bites and landings. CEO Frank D. Heuszel highlighted the need for innovative healthcare solutions and is pursuing partnerships for market expansion. Both patents will expire between 2039 and 2040.

September 26, 2024
3 Articles

Further Reading